当前位置: 首页 >> 检索结果
共有 6650 条符合本次的查询结果, 用时 2.7200869 秒

4501. Response.

作者: Sarah Svenningsen.;Parameswaran Nair.
来源: Chest. 2019年156卷4期808-809页

4502. CT and Functional MRI to Evaluate Airway Mucus in Severe Asthma.

作者: Shinichiro Okauchi.;Hideyasu Yamada.;Hiroaki Satoh.
来源: Chest. 2019年156卷4期808页

4503. Reducing COPD Readmissions: Strategies for the Pulmonologist to Improve Outcomes.

作者: Neil Freedman.
来源: Chest. 2019年156卷4期802-807页
Hospitalizations for patients with acute exacerbations of COPD are associated with several adverse patient outcomes as well as with significant health-care costs. Despite many interventions targeted at reducing readmissions following an initial hospitalization, there are few strategies that have been consistently associated with reductions in this outcome. Despite the lack of consensus as to the best strategies to deploy to reduce readmissions related to acute exacerbations of COPD, efforts must continue to focus on determining the best approaches for this population. These tactics will need to be cost-effective for payers while not being cost-prohibitive for providers. In addition, these interventions will need to be relatively easy to institute while not being overbearing for patients or providers. Larger systems with their greater financial resources will likely find success with technology and data-driven comprehensive programs; independent hospitals and practices are more likely to succeed with less resource-intensive interventions such as early postdischarge follow-up, coaching, action plans, self-management education, and pulmonary rehabilitation. Choosing the right interventions that will utilize financial and human resources in a cost-effective manner, while tailoring the approaches to meet the needs of a specific patient group, will be of key importance.

4504. Rebuttal From Drs Patel and Bergl.

作者: Jayshil J Patel.;Paul A Bergl.
来源: Chest. 2019年156卷4期651-652页

4505. Rebuttal From Drs Disselkamp, Coz Yataco, and Simpson.

作者: Margaret Disselkamp.;Angel O Coz Yataco.;Steven Q Simpson.
来源: Chest. 2019年156卷4期649-650页

4506. COUNTERPOINT: Should Broad-Spectrum Antibiotics Be Routinely Administered to All Patients With Sepsis as Soon as Possible? No.

作者: Jayshil J Patel.;Paul A Bergl.
来源: Chest. 2019年156卷4期647-649页

4507. POINT: Should Broad-Spectrum Antibiotics Be Routinely Administered to All Patients With Sepsis as Soon as Possible? Yes.

作者: Margaret Disselkamp.;Angel O Coz Yataco.;Steven Q Simpson.
来源: Chest. 2019年156卷4期645-647页

4508. Shining Light on Pleural Biopsy in Mesothelioma: Is It Time to Get "Smart"?

作者: Eihab O Bedawi.;Najib M Rahman.
来源: Chest. 2019年156卷4期643-644页

4509. Do Cough and Sputum Production Predict COPD Exacerbations?: The Evidence Is Growing.

作者: Clémence Martin.;Pierre-Régis Burgel.
来源: Chest. 2019年156卷4期641-642页

4510. The Search for Optimal Oxygen Saturation Targets in Critically Ill Patients: Observational Data From Large ICU Databases.

作者: Willem van den Boom.;Michael Hoy.;Jagadish Sankaran.;Mengru Liu.;Haroun Chahed.;Mengling Feng.;Kay Choong See.
来源: Chest. 2020年157卷3期566-573页
Although low oxygen saturations are generally regarded as deleterious, recent studies in ICU patients have shown that a liberal oxygen strategy increases mortality. However, the optimal oxygen saturation target remains unclear. The goal of this study was to determine the optimal range by using real-world data.

4511. Comparative Effectiveness of Robotic-Assisted Surgery for Resectable Lung Cancer in Older Patients.

作者: Rajwanth R Veluswamy.;Stacey-Ann Whittaker Brown.;Grace Mhango.;Keith Sigel.;Daniel G Nicastri.;Cardinale B Smith.;Marcelo Bonomi.;Matthew D Galsky.;Emanuela Taioli.;Alfred I Neugut.;Juan P Wisnivesky.
来源: Chest. 2020年157卷5期1313-1321页
Robotic-assisted surgery (RAS) is a novel surgical approach increasingly used for patients with non-small cell lung cancer (NSCLC). However, data comparing the effectiveness and costs of RAS vs open thoracotomy and video-assisted thoracoscopic surgery (VATS) for NSCLC are limited.

4512. Allergic Rhinitis and OSA in Children Residing at a High Altitude.

作者: Luis Fernando Giraldo-Cadavid.;Karen Perdomo-Sanchez.;Jorge Luis Córdoba-Gravini.;Maria Isabel Escamilla.;Miguel Suarez.;Natalia Gelvez.;David Gozal.;Elida Duenas-Meza.
来源: Chest. 2020年157卷2期384-393页
OSA affects 2% to 4 % of the pediatric population; allergic rhinitis (AR) has been identified as a risk factor in sleep-disordered breathing, but no studies evaluating such an association have been conducted in high-altitude environments. The goal of this study was to assess whether the severity of AR is associated with the severity of OSA in children undergoing polysomnography (PSG) in the high-altitude city of Bogotá, Colombia.

4513. Better With Ultrasound: Transcranial Doppler.

作者: Vincent I Lau.;Atul Jaidka.;Katie Wiskar.;Nicholas Packer.;J Elaine Tang.;Seth Koenig.;Scott J Millington.;Robert T Arntfield.
来源: Chest. 2020年157卷1期142-150页
Transcranial Doppler (TCD) ultrasound is a noninvasive method of obtaining bedside neurologic information that can supplement the physical examination. In critical care, this can be of particular value in patients who are unconscious with an equivocal neurologic examination because TCD findings can help the physician in decisions related to more definitive imaging studies and potential clinical interventions. Although TCD is traditionally the domain of sonographers and radiologists, there is increasing adoption of goal-directed TCD at the bedside in the critical care environment. The value of this approach includes round-the-clock availability and a goal-directed approach allowing for repeatability, immediate interpretation, and quick clinical integration. This paper presents a systematic approach to incorporating the highest yield TCD techniques into critical care bedside practice, and includes a series of illustrative figures and narrated video presentations to demonstrate the techniques described.

4514. Risk Reduction and Right Heart Reverse Remodeling by Upfront Triple Combination Therapy in Pulmonary Arterial Hypertension.

作者: Michele D'Alto.;Roberto Badagliacca.;Paola Argiento.;Emanuele Romeo.;Andrea Farro.;Silvia Papa.;Berardo Sarubbi.;Maria Giovanna Russo.;Carmine Dario Vizza.;Paolo Golino.;Robert Naeije.
来源: Chest. 2020年157卷2期376-383页
Combinations of therapies are currently recommended for patients with severe pulmonary arterial hypertension (PAH), and excellent results have been reported with triple upfront combination of these drugs. We evaluated the effects of this approach on right ventricular (RV) function and outcome in patients with severe PAH.

4515. Retrospective Validation of the REVEAL 2.0 Risk Score With the Australian and New Zealand Pulmonary Hypertension Registry Cohort.

作者: James J Anderson.;Edmund M Lau.;Melanie Lavender.;Raymond Benza.;David S Celermajer.;Nicholas Collins.;Carolyn Corrigan.;Nathan Dwyer.;John Feenstra.;Mark Horrigan.;Dominic Keating.;Fiona Kermeen.;Eugene Kotlyar.;Tanya McWilliams.;Bronwen Rhodes.;Peter Steele.;Vivek Thakkar.;Trevor Williams.;Helen Whitford.;Kenneth Whyte.;Robert Weintraub.;Jeremy P Wrobel.;Anne Keogh.;Geoff Strange.
来源: Chest. 2020年157卷1期162-172页
Pulmonary arterial hypertension (PAH) prognosis has improved with targeted therapies; however, the long-term outlook remains poor. Objective multiparametric risk assessment is recommended to identify patients at risk of early morbidity and mortality, and for optimization of treatment. The US Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL) 2.0 risk score is a new model proposed for the follow-up of patients with PAH but has not been externally validated.

4516. Whole Genome Sequencing Identifies CRISPLD2 as a Lung Function Gene in Children With Asthma.

作者: Priyadarshini Kachroo.;Julian Hecker.;Bo L Chawes.;Tarunveer S Ahluwalia.;Michael H Cho.;Dandi Qiao.;Rachel S Kelly.;Su H Chu.;Yamini V Virkud.;Mengna Huang.;Kathleen C Barnes.;Esteban G Burchard.;Celeste Eng.;Donglei Hu.;Juan C Celedón.;Michelle Daya.;Albert M Levin.;Hongsheng Gui.;L Keoki Williams.;Erick Forno.;Angel C Y Mak.;Lydiana Avila.;Manuel E Soto-Quiros.;Michelle M Cloutier.;Edna Acosta-Pérez.;Glorisa Canino.;Klaus Bønnelykke.;Hans Bisgaard.;Benjamin A Raby.;Christoph Lange.;Scott T Weiss.;Jessica A Lasky-Su.; .
来源: Chest. 2019年156卷6期1068-1079页
Asthma is a common respiratory disorder with a highly heterogeneous nature that remains poorly understood. The objective was to use whole genome sequencing (WGS) data to identify regions of common genetic variation contributing to lung function in individuals with a diagnosis of asthma.

4517. An Individualized Prediction Model for Long-term Lung Function Trajectory and Risk of COPD in the General Population.

作者: Wenjia Chen.;Don D Sin.;J Mark FitzGerald.;Abdollah Safari.;Amin Adibi.;Mohsen Sadatsafavi.
来源: Chest. 2020年157卷3期547-557页
Prediction of future lung function will enable the identification of individuals at high risk of developing COPD, but the trajectory of lung function decline varies greatly among individuals. This study involved the development and validation of an individualized prediction model of lung function trajectory and risk of airflow limitation in the general population.

4518. Sleep Apnea and Chronic Kidney Disease: A State-of-the-Art Review.

作者: Chou-Han Lin.;Renee C Lurie.;Owen D Lyons.
来源: Chest. 2020年157卷3期673-685页
Patients with chronic kidney disease have increased morbidity and mortality, mainly due to cardiovascular disease. Compared with the general population, patients with chronic kidney disease have an increased prevalence of both OSA and central sleep apnea, and the presence of sleep apnea in this population has been associated with an increased risk of cardiovascular events and mortality. Although OSA can lead to an increase in the rate of kidney function decline, there is also evidence that the presence of end-stage renal disease can lead to worsening of sleep apnea, indicating a bidirectional relation between sleep apnea and chronic kidney disease. The objective of this review was to describe the epidemiology of sleep apnea in chronic kidney disease, understand the pathophysiological mechanisms by which OSA can lead to progression of chronic kidney disease, and consider the role of treatment with CPAP in this regard. The review also explores the pathophysiological mechanism by which end-stage renal disease can lead to sleep apnea and considers how intensification of renal replacement therapy or extra fluid removal by ultrafiltration may attenuate the degree of sleep apnea severity in this population.

4519. Respiratory Duty Cycles in Individuals With and Without Airway Hyperresponsiveness.

作者: Christianne M Blais.;Beth E Davis.;Brian L Graham.;Donald W Cockcroft.
来源: Chest. 2020年157卷2期356-362页
The respiratory duty cycle (Ti/Ttot) can influence bronchoprovocation test results and nebulized drug delivery. The Ti/Ttot has not yet been examined in individuals with airway hyperresponsiveness (AHR) in typical bronchoprovocation test conditions. This study investigated the mean Ti/Ttot in participants with and without AHR and whether the Ti/Ttot changes with increasing bronchoconstriction.

4520. Circulating Endometrial Cells in Women With Spontaneous Pneumothorax.

作者: Imrich Kiss.;Eliska Pospisilova.;Katarina Kolostova.;Vilem Maly.;Ivan Stanek.;Robert Lischke.;Jan Schutzner.;Ireneusz Pawlak.;Vladimir Bobek.
来源: Chest. 2020年157卷2期342-355页
The occurrence of catamenial pneumothorax (CP) is rare, and the awareness of this diagnosis among physicians is insufficient. CP is highly correlated with pelvic endometriosis and remains the most common form of thoracic endometriosis syndrome. Circulating endometrial cells (CECs) have been previously detected in patients with pelvic endometriosis. Could CECs bring new insights into pneumothorax management?
共有 6650 条符合本次的查询结果, 用时 2.7200869 秒